Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy
- Aliment. Pharmacol. Ther., Volume 46, Issue 9, November 2017, Pages 845-855 | https://doi.org/10.1111/apt.14275